Homestead Advisers Corp Has $40.11 Million Stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Homestead Advisers Corp grew its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 43.2% during the 4th quarter, HoldingsChannel reports. The firm owned 513,100 shares of the company’s stock after acquiring an additional 154,700 shares during the quarter. Homestead Advisers Corp’s holdings in GE HealthCare Technologies were worth $40,114,000 as of its most recent filing with the SEC.

A number of other institutional investors have also made changes to their positions in GEHC. NEOS Investment Management LLC lifted its holdings in shares of GE HealthCare Technologies by 23.9% during the fourth quarter. NEOS Investment Management LLC now owns 53,048 shares of the company’s stock worth $4,147,000 after buying an additional 10,219 shares during the last quarter. UniSuper Management Pty Ltd grew its position in GE HealthCare Technologies by 34.5% in the 4th quarter. UniSuper Management Pty Ltd now owns 40,492 shares of the company’s stock worth $3,166,000 after purchasing an additional 10,379 shares during the last quarter. JPMorgan Chase & Co. raised its position in shares of GE HealthCare Technologies by 53.5% during the fourth quarter. JPMorgan Chase & Co. now owns 3,428,586 shares of the company’s stock valued at $268,047,000 after buying an additional 1,194,983 shares during the last quarter. Elo Mutual Pension Insurance Co lifted its stake in shares of GE HealthCare Technologies by 22.8% in the fourth quarter. Elo Mutual Pension Insurance Co now owns 47,008 shares of the company’s stock valued at $3,675,000 after buying an additional 8,729 shares during the period. Finally, Mitsubishi UFJ Asset Management Co. Ltd. increased its stake in GE HealthCare Technologies by 10.9% during the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 746,595 shares of the company’s stock valued at $60,116,000 after acquiring an additional 73,578 shares during the period. 82.06% of the stock is currently owned by institutional investors.

GE HealthCare Technologies Trading Down 1.8 %

GEHC stock opened at $81.00 on Thursday. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.04 and a quick ratio of 0.83. The stock has a market capitalization of $37.04 billion, a price-to-earnings ratio of 18.71, a P/E/G ratio of 3.19 and a beta of 1.13. The business has a fifty day moving average price of $86.86 and a 200 day moving average price of $85.93. GE HealthCare Technologies Inc. has a fifty-two week low of $74.51 and a fifty-two week high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings results on Thursday, February 13th. The company reported $1.45 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.26 by $0.19. The business had revenue of $5.32 billion for the quarter, compared to the consensus estimate of $5.33 billion. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. Analysts expect that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

Analyst Ratings Changes

A number of brokerages have commented on GEHC. Wells Fargo & Company raised their price objective on GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an “overweight” rating in a research report on Friday, February 14th. Citigroup boosted their price target on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the company a “buy” rating in a report on Thursday, February 13th. Jefferies Financial Group raised shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and raised their price objective for the stock from $95.00 to $103.00 in a report on Wednesday, January 8th. Finally, The Goldman Sachs Group raised shares of GE HealthCare Technologies from a “neutral” rating to a “buy” rating and increased their price target for the stock from $85.00 to $100.00 in a research report on Tuesday, March 11th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating, nine have given a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $98.75.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.